---
figid: PMC9559307__cancers-14-04602-g001
figtitle: Biomarkers in the Management of Colorectal Liver Metastases
organisms:
- NA
pmcid: PMC9559307
filename: cancers-14-04602-g001.jpg
figlink: /pmc/articles/PMC9559307/figure/cancers-14-04602-f001/
number: F1
caption: Overview of interlinked cellular signaling pathways involved in the proliferation
  and progression of colorectal cancer. In pathway A, TP53 normally inhibits activated
  RAS through lethal (Let) 7a23. However, Let-7a is not able to regulate activated
  RAS if TP53 is mutated. In pathway B, overactive phosphoinositide 3-kinase (PI3K),
  an oncogene, inhibits glycogen synthase kinase (GSK) 3β24, leading to β-catenin
  accumulation. EGF, epidermal growth factor; HER, human epidermal growth factor receptor;
  RTK, receptor tyrosine kinase; MEK, mitogen-activated protein kinase; ErK, extracellular
  signal-regulated kinase; Mt, mitochondria; IGF-1, insulin-like growth factor 1;
  IGF-1R/IR, IGF-1 receptor/insulin receptor; PIP2, phosphatidylinositol 4,5-bisphosphate;
  PTEN, phosphatase and tensin homologue; PIP3, phosphatidylinositol (3,4,5)-trisphosphate;
  PDK-1, phosphoinositide-dependent protein kinase 1; mTORC1/2, mammalian target of
  rapamycin complex 1/2; P70s6k, P70s6 kinase; APC, adenomatous polyposis coli. Used
  with permission [].
papertitle: The Role of Biomarkers in the Management of Colorectal Liver Metastases.
reftext: Daniel Brock Hewitt, et al. Cancers (Basel). 2022 Oct;14(19):4602.
year: '2022'
doi: 10.3390/cancers14194602
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: colorectal cancer | colorectal liver metastasis | biomarker | ctDNA | radiomics
automl_pathway: 0.9410418
figid_alias: PMC9559307__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9559307__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9559307__cancers-14-04602-g001.html
  '@type': Dataset
  description: Overview of interlinked cellular signaling pathways involved in the
    proliferation and progression of colorectal cancer. In pathway A, TP53 normally
    inhibits activated RAS through lethal (Let) 7a23. However, Let-7a is not able
    to regulate activated RAS if TP53 is mutated. In pathway B, overactive phosphoinositide
    3-kinase (PI3K), an oncogene, inhibits glycogen synthase kinase (GSK) 3β24, leading
    to β-catenin accumulation. EGF, epidermal growth factor; HER, human epidermal
    growth factor receptor; RTK, receptor tyrosine kinase; MEK, mitogen-activated
    protein kinase; ErK, extracellular signal-regulated kinase; Mt, mitochondria;
    IGF-1, insulin-like growth factor 1; IGF-1R/IR, IGF-1 receptor/insulin receptor;
    PIP2, phosphatidylinositol 4,5-bisphosphate; PTEN, phosphatase and tensin homologue;
    PIP3, phosphatidylinositol (3,4,5)-trisphosphate; PDK-1, phosphoinositide-dependent
    protein kinase 1; mTORC1/2, mammalian target of rapamycin complex 1/2; P70s6k,
    P70s6 kinase; APC, adenomatous polyposis coli. Used with permission [].
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - EGF
  - KRAS
  - HRAS
  - NRAS
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - EPHB2
  - MAPK1
  - MAPK3
  - BAD
  - BAX
  - TP53
  - TP63
  - TP73
  - PTEN
  - IGF1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - PDK1
  - PDPK1
  - AKT1
  - AKT2
  - AKT3
  - MTOR
  - RPTOR
  - RPS6KB1
  - RPS6KB2
  - IGF1R
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - MAPKAP1
  - RICTOR
  - MLST8
  - GSK3B
  - APC
  - PROC
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - CTNNB1
---
